Speaker(s):
Bernie Eck, RPh, CDCES, – Clinical Pharmacist, Geisinger MTM Clinic, Scenery Park PA - has nothing to disclose.
Moderator(s):
Stacy Coolbaugh, MBA, RDN, LDN, - Director, Outpatient Nutrition Services, Geisinger Medical Center, Wilkes-Barre PA - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
Understand the impact of glucocorticoids on blood glucose levels: Recognize how glucocorticoids (GCs) can lead to steroid-induced hyperglycemia (SIHG) and its implications for patients
Understand the impact of steroid medications on blood glucose levels: Recognize how different types of steroids and their administration methods affect blood glucose.
Monitor blood glucose levels effectively: Learn the importance of frequent monitoring and how to adjust diabetes management accordingly.
Manage diabetes while on steroid medication: Get guidance on adjusting diabetes medication and insulin doses.
Educate patients and healthcare providers: Provide information on safe steroid use and diabetes management.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Esherick, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH; Amy Luzier Barrett, RN, MSN, MEd, and Joey Underhill have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
- 1.00 ACPE
- 1.00 ANCC
- 1.00 CDR
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward